RxDoctor Payments Data

Brian Jones, MD

Family Medicine · Cedar Hill, TXNPI 1225002298

Payments from drug & device makers

$16,743in general payments, 2019–2025

Across 60 payments — averaging $279.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$16K
  • Novo Nordisk$177
  • AstraZeneca$157
  • Gilead$114
  • Lilly USA, LLC$95
  • Hologic Sales And Service, LLC$93
  • plus $308 from 9 others

What the payments were for

  • Consulting fees$4,15025%
  • Speaking & faculty fees$10,10060%
  • Travel & lodging$1,1537%
  • Food & beverage$1,3408%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,743 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$28,419
Medicare patients
70
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$40,842
TrulicityDulaglutide24$40,000
MounjaroTirzepatide18$18,842
JanuviaSitagliptin Phosphate11$16,028
JanumetSitagliptin Phos/Metformin Hcl11$14,730
FarxigaDapagliflozin Propanediol19$11,335
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,230
Atorvastatin Calcium125$1,379
Albuterol Sulfate HfaAlbuterol Sulfate25$1,076
Rosuvastatin Calcium66$910
Tamsulosin Hcl28$628
Gabapentin52$589
Amlodipine-ValsartanAmlodipine Besylate/Valsartan14$588
SynthroidLevothyroxine Sodium13$560
Lisinopril61$532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$95$58,84142 claims
Novo NordiskOzempic$177$40,84233 claims
AstraZenecaFarxiga$157$11,33519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Cedar Hill

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →